Indaptus Therapeutics (NASDAQ:INDP) announced proposed resale of up to 1.94M shares by selling shareholders. The company will not receive any proceeds from the sale. Souce: SEC Filing

More on Indaptus Therapeutics

Indaptus Therapeutics announces $2.135M registered direct offering Indaptus Therapeutics signs clinical supply agreement with BeiGene Seeking Alpha's Quant Rating on Indaptus Therapeutics Historical earnings data for Indaptus Therapeutics Financial information for Indaptus Therapeutics